Stocks and Investing
Stocks and Investing
Thu, June 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Emily Bodnar Reiterated (VTYX) at Hold and Held Target at $6 on, Jun 13th, 2024
Emily Bodnar of HC Wainwright & Co., Reiterated "Ventyx Biosciences, Inc." (VTYX) at Hold and Held Target at $6 on, Jun 13th, 2024.
Emily has made no other calls on VTYX in the last 4 months.
There are 3 other peers that have a rating on VTYX. Out of the 3 peers that are also analyzing VTYX, 0 agree with Emily's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Emily
- Jeff Jones of "Oppenheimer" Maintained at Buy with Decreased Target to $10 on, Thursday, June 6th, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $15 on, Wednesday, March 13th, 2024
- Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $16 on, Tuesday, March 12th, 2024
Contributing Sources